Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations
| Autor: | Takeyasu, Yuki, Yoshida, Tatsuya, Masuda, Ken, Matsumoto, Yuji, Shinno, Yuki, Okuma, Yusuke, Goto, Yasushi, Horinouchi, Hidehito, Yamamoto, Noboru, Ohe, Yuichiro |
|---|---|
| Zdroj: | In JTO Clinical and Research Reports February 2024 5(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|